Latest Communications

16 January 2013
MonoSol Rx Enters Into Licensing Agreement With Vestiq Pharmaceuticals for Zuplenz(R) Oral Soluble Film

19 November 2012
APR Applied Pharma Research ("APR") and Labtec GmbH ("Labtec") announce the European approval of two new Oral Dispersible Film (ODF) based respectively on Olanzapine and Donepezil

05 October 2012
Stellar Pharmaceuticals Launches New Migraine Treatment, CAMBIA®, in $150 Million Canadian Prescription Migraine Market


Think Tank


For all those companies and Inventors who own innovative projects for which they wish to maintain an active role in exploiting them but do not have either development and marketing Know How or the required financial resources, we have created a great place where such projects can be shaped: we call it "Think Tank".


In the Think Tank area, APR is acting as a mix of strategic and financial investor able to provide a balanced mix of capital funding and development Know How channeled into a new company created ad hoc for that specific project and where the inventor can maintain an equity position enabling him to secure the upside potential.


We welcome your ideas and we will carefully listen to them: we will openly and professionally evaluate them all.





Search results